Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas

Human Molecular Genetics

Volumn 21, Issue 26, 2012, Pages 5406-5416

  Welander, Jenny ^a   Larsson, Catharina ^b   Bäckdahl, Martin ^b   Hareni, Niyaz ^a   Sivlér, Tobias ^a   Brauckhoff, Michael ^c   Söderkvist, Peter ^a   Gimm, Oliver ^a,d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Centre of Surgery and Oncology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METADRENALIN; NORMETADRENALIN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GENE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIF1BBETA GENE; MAX GENE; MUTATIONAL ANALYSIS; NF1 GENE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROMOTER REGION; RET GENE; SDHA GENE; SDHAF2 GENE; SDHB GENE; SDHC GENE; SDHD GENE; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TMEM127 GENE; VHL GENE;

ALLELES; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEUROFIBROMATOSIS 1; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PHEOCHROMOCYTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84870801743     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds402     Document Type: Article

References (55)

1. Karagiannis, A., Mikhailidis, D.P., Athyros, V.G. and Harsoulis, F. (2007) Pheochromocytoma: an update on genetics and management. Endocr. Relat. Cancer, 14, 935-956.
2. Welander, J., Soderkvist, P. and Gimm, O. (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr. Relat. Cancer, 18, R253-R276.
3. Gimm, O., Demicco, C., Perren, A., Giammarile, F., Walz, M.K. and Brunaud, L. (2012) Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. Langenbecks Arch. Surg., 397, 155-177.
4. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
5. Lohmann, D. (2010) Retinoblastoma. Adv. Exp. Med. Biol., 685, 220-227.
6. Waldmann, J., Langer, P., Habbe, N., Fendrich, V., Ramaswamy, A., Rothmund, M., Bartsch, D.K. and Slater, E.P. (2009) Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas. Endocrine, 35, 347-355.
7. Korpershoek, E., Petri, B.J., van Nederveen, F.H., Dinjens, W.N., Verhofstad, A.A., de Herder, W.W., Schmid, S., Perren, A., Komminoth, P. and de Krijger, R.R. (2007) Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Endocr. Relat. Cancer, 14, 453-462.
8. Burnichon, N., Vescovo, L., Amar, L., Libe, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J. et al. (2011) Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum. Mol. Genet., 20, 3974-3985.
9. Bayley, J.P., Kunst, H.P.M., Cascon, A., Sampietro, M.L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H.J.L.M., Hoefsloot, L.H., Hermsen, M.A. et al. (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol., 11, 366-372.
10. Gimm, O., Armanios, M., Dziema, H., Neumann, H.P. and Eng, C. (2000) Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res., 60, 6822-6825.
11. Burnichon, N., Cascon, A., Schiavi, F., Morales, N.P., Comino-Mendez, I., Abermil, N., Inglada-Perez, L., de Cubas, A.A., Amar, L., Barontini, M. et al. (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin. Cancer Res., 18, 2828-2837.
12. Weber, A., Hoffmann, M.M., Neumann, H.P. and Erlic, Z. (2012) Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma. Horm. Cancer, 3, 187-192.
13. Eisenhofer, G., Huynh, T.T., Pacak, K., Brouwers, F.M., Walther, M.M., Linehan, W.M., Munson, P.J., Mannelli, M., Goldstein, D.S. and Elkahloun, A.G. (2004) Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr. Relat. Cancer, 11, 897-911.
14. Dahia, P.L., Ross, K.N., Wright, M.E., Hayashida, C.Y., Santagata, S., Barontini, M., Kung, A.L., Sanso, G., Powers, J.F., Tischler, A.S. et al. (2005) A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet., 1, 72-80.
15. Lopez-Jimenez, E., Gomez-Lopez, G., Leandro-Garcia, L.J., Munoz, I., Schiavi, F., Montero-Conde, C., de Cubas, A.A., Ramires, R., Landa, I., Leskela, S. et al. (2010) Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol. Endocrinol., 24, 2382-2391.
16. Yeh, I.T., Lenci, R.E., Qin, Y., Buddavarapu, K., Ligon, A.H., Leteurtre, E., Do Cao, C., Cardot-Bauters, C., Pigny, P. and Dahia, P.L. (2008) A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum. Genet., 124, 279-285.
17. Qin, Y., Yao, L., King, E.E., Buddavarapu, K., Lenci, R.E., Chocron, E.S., Lechleiter, J.D., Sass, M., Aronin, N., Schiavi, F. et al. (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat. Genet., 42, 229-233.
18. Comino-Mendez, I., Gracia-Aznarez, F.J., Schiavi, F., Landa, I., Leandro-Garcia, L.J., Leton, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G. et al. (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet., 43, 663-667.
19. Eisenhofer, G., Pacak, K., Huynh, T.T., Qin, N., Bratslavsky, G., Linehan, W.M., Mannelli, M., Friberg, P., Grebe, S.K., Timmers, H.J. et al. (2011) Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr. Relat. Cancer, 18, 97-111.
20. Boyd, K.P., Korf, B.R. and Theos, A. (2009) Neurofibromatosis type 1. J. Am. Acad. Dermatol., 61, 1-14; quiz 15-16.
21. Musholt, P.B., Musholt, T.J., Goodfellow, P.J., Zehnbauer, B.A., Wells, S.A. Jr. and Moley, J.F. (1997) 'Cold' single-strand conformational variants for mutation analysis of the RET protooncogene. Surgery, 122, 363-370; discussion 370-361.
22. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
23. Cascon, A., Ruiz-Llorente, S., Cebrian, A., Leton, R., Telleria, D., Benitez, J. and Robledo, M. (2003) G12S and H50R variations are polymorphisms in the SDHD gene. Genes Chromosomes Cancer, 37, 220-221.
24. van Nederveen, F.H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R.A., de Bruyn, E.M., Sleddens, H.F., Derkx, P., Riviere, J., Dannenberg, H. et al. (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol., 10, 764-771.
25. Gill, A.J., Benn, D.E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G.Y., Richardson, A.L., Sidhu, S.B., Robinson, B.G. and Clifton-Bligh, R.J. (2010) Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum. Pathol., 41, 805-814.
26. Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.P. et al. (2011) SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J. Clin. Endocrinol. Metab., 96, E1472-E1476.
27. van Nederveen, F.H., Korpershoek, E., deLeeuw, R.J., Verhofstad, A.A., Lenders, J.W., Dinjens, W.N., Lam, W.L. and de Krijger, R.R. (2009) Array-comparative genomic hybridization in sporadic benign pheochromocytomas. Endocr. Relat. Cancer, 16, 505-513.
28. Sandgren, J., Diaz de Stahl, T., Andersson, R., Menzel, U., Piotrowski, A., Nord, H., Backdahl, M., Kiss, N.B., Brauckhoff, M., Komorowski, J. et al. (2010) Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis. Endocr. Relat. Cancer, 17, 561-579.
29. Fang, L.J., Simard, M.J., Vidaud, D., Assouline, B., Lemieux, B., Vidaud, M., Chabot, B. and Thirion, J.P. (2001) A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. J. Mol. Biol., 307, 1261-1270.
30. Chang, Y.F., Imam, J.S. and Wilkinson, M.F. (2007) The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem., 76, 51-74.
31. International HapMap Consortium (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
32. Lenders, J.W., Pacak, K., Walther, M.M., Linehan, W.M., Mannelli, M., Friberg, P., Keiser, H.R., Goldstein, D.S. and Eisenhofer, G. (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA, 287, 1427-1434.
33. Knudson, A.G. (1996) Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol., 122, 135-140.
34. Margetts, C.D., Astuti, D., Gentle, D.C., Cooper, W.N., Cascon, A., Catchpoole, D., Robledo, M., Neumann, H.P., Latif, F. and Maher, E.R. (2005) Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic pheochromocytomas. Endocr. Relat. Cancer, 12, 161-172.
35. Martin, G.A., Viskochil, D., Bollag, G., McCabe, P.C., Crosier, W.J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R.M. et al. (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell, 63, 843-849.
36. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
37. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
38. Ding, L., Getz, G., Wheeler, D.A., Mardis, E.R., McLellan, M.D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D.M., Morgan, M.B. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
39. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609-615.
40. Bausch, B., Borozdin, W., Mautner, V.F., Hoffmann, M.M., Boehm, D., Robledo, M., Cascon, A., Harenberg, T., Schiavi, F., Pawlu, C. et al. (2007) Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type. J. Clin. Endocrinol. Metab., 92, 2784-2792.
41. Upadhyaya, M., Han, S., Consoli, C., Majounie, E., Horan, M., Thomas, N.S., Potts, C., Griffiths, S., Ruggieri, M., von Deimling, A. et al. (2004) Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum. Mutat., 23, 134-146.
42. Wimmer, K., Roca, X., Beiglbock, H., Callens, T., Etzler, J., Rao, A.R., Krainer, A.R., Fonatsch, C. and Messiaen, L. (2007) Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5′ splice-site disruption. Hum. Mutat., 28, 599-612.
43. Ars, E., Serra, E., Garcia, J., Kruyer, H., Gaona, A., Lazaro, C. and Estivill, X. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet., 9, 237-247.
44. Gasparini, P., D'Agruma, L., Pio de Cillis, G., Balestrazzi, P., Mingarelli, R. and Zelante, L. (1996) Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: identification of three novel mutations and of two new polymorphisms. Hum. Genet., 97, 492-495.
45. Messiaen, L.M., Callens, T., Roux, K.J., Mortier, G.R., De Paepe, A., Abramowicz, M., Pericak-Vance, M.A., Vance, J.M. and Wallace, M.R. (1999) Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing. Genet. Med., 1, 248-253.
46. Eisenhofer, G., Lenders, J.W., Timmers, H., Mannelli, M., Grebe, S.K., Hofbauer, L.C., Bornstein, S.R., Tiebel, O., Adams, K., Bratslavsky, G. et al. (2011) Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin. Chem., 57, 411-420.
47. de Kok, J.B., Roelofs, R.W., Giesendorf, B.A., Pennings, J.L., Waas, E.T., Feuth, T., Swinkels, D.W. and Span, P.N. (2005) Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. Invest., 85, 154-159.
48. Schmittgen, T.D. and Livak, K.J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
49. Aranyi, T., Varadi, A., Simon, I. and Tusnady, G.E. (2006) The BiSearch web server. BMC Bioinformatics, 7, 431.
50. Barron, V.A. and Lou, H. (2012) Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci. Rep., 32, 131-138.
51. Shapiro, M.B. and Senapathy, P. (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155-7174.
52. Espina, V., Wulfkuhle, J.D., Calvert, V.S., VanMeter, A., Zhou, W., Coukos, G., Geho, D.H., Petricoin, E.F. III and Liotta, L.A. (2006) Laser-capture microdissection. Nat. Protoc., 1, 586-603.
53. Li, L.C. and Dahiya, R. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics, 18, 1427-1431.
54. Banks, R.E., Tirukonda, P., Taylor, C., Hornigold, N., Astuti, D., Cohen, D., Maher, E.R., Stanley, A.J., Harnden, P., Joyce, A. et al. (2006) Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res., 66, 2000-2011.
55. Dong, S.M., Kim, H.S., Rha, S.H. and Sidransky, D. (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res., 7, 1982-1986.